Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV was delisted on the 31st of July, 2023.
20 hedge funds and large institutions have $88M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 20 → 20 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
24% less capital invested
Capital invested by funds: $116M → $88M (-$28.5M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$1.45M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$564K |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$371K |
| 4 |
FO
FT Options
Chicago,
Illinois
|
+$212K |
| 5 |
JPC
Jackson Park Capital
Alpine,
Utah
|
+$210K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WT
Wellcome Trust
London,
United Kingdom
|
-$9.49M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.09M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$1.17M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$269K |
| 5 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$137K |
NBRV Hedge Fund Activity: Q2 2016 in Review
20 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) for Q2 2016, worth a combined $88M — down 24% from $116M a quarter earlier.
Fund positioning in NBRV was balanced in Q2 2016: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 5 trimmed.
The largest buyer was Novo Holdings A/S, adding an estimated $1.45M. The largest seller was Wellcome Trust, cutting an estimated $9.49M.
- 20 institutional investors held Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $88M of Nabriva Therapeutics plc Ordinary Shares Ireland stock for Q2 2016, down 24% quarter-over-quarter.
- 3 funds opened new Nabriva Therapeutics plc Ordinary Shares Ireland positions in Q2 2016 and 3 closed out, a net change of 0 holders.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland buyer in Q2 2016 was Novo Holdings A/S, an estimated $1.45M added.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland seller in Q2 2016 was Wellcome Trust, an estimated $9.49M sold.
Based on aggregated 13F filings for Q2 2016.